Socrates Health Solutions, Inc. — SEC Form D Filing

Socrates Health Solutions, Inc. filed an SEC Form D on June 2, 2026, reporting $1.50M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
June 2, 2026
Amount reported
$1.50M
Round stage
Seed
Industry
Health Technology
Website
https://socrateshealthsolutions.com/

What the company does

Securities: Equity, Debt. Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Managing diabetes effectively requires real-time monitoring and control of blood glucose levels, however current methods often involve invasive procedures like needle insertion or finger pricks.

Solution

Socrates Health Solutions is developing non-invasive blood glucose monitoring devices such as CompanionCM, CompanionSR, and CompanionLS that provide real-time data and eliminate the need for needles and finger pricks.

Why now

There is a growing need for more convenient and less painful solutions for blood glucose monitoring as diabetes prevalence increases.

Verdict

Investors said yes at this moment because the demand for non-invasive diabetes management was creating a significant market opportunity, not because traditional methods were inherently flawed. They were implicitly betting on the growing discomfort with invasive procedures and the broader trend towards user-friendly healthcare solutions. However, the limited upside lies in the potential for competition from both established players and new entrants who could easily replicate the technology, impacting durability.

Source: SEC EDGAR Form D filing